BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 36865541)

  • 21. Modulation of Toll-interleukin 1 receptor mediated signaling.
    Li X; Qin J
    J Mol Med (Berl); 2005 Apr; 83(4):258-66. PubMed ID: 15662540
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MyD88 oligomer size functions as a physical threshold to trigger IL1R Myddosome signaling.
    Deliz-Aguirre R; Cao F; Gerpott FHU; Auevechanichkul N; Chupanova M; Mun Y; Ziska E; Taylor MJ
    J Cell Biol; 2021 Jul; 220(7):. PubMed ID: 33956941
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IRAK1: a critical signaling mediator of innate immunity.
    Gottipati S; Rao NL; Fung-Leung WP
    Cell Signal; 2008 Feb; 20(2):269-76. PubMed ID: 17890055
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation of interleukin-1- and lipopolysaccharide-induced NF-kappaB activation by alternative splicing of MyD88.
    Janssens S; Burns K; Tschopp J; Beyaert R
    Curr Biol; 2002 Mar; 12(6):467-71. PubMed ID: 11909531
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MyD88 Death-Domain Oligomerization Determines Myddosome Architecture: Implications for Toll-like Receptor Signaling.
    Moncrieffe MC; Bollschweiler D; Li B; Penczek PA; Hopkins L; Bryant CE; Klenerman D; Gay NJ
    Structure; 2020 Mar; 28(3):281-289.e3. PubMed ID: 31995744
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Experimental and natural infections in MyD88- and IRAK-4-deficient mice and humans.
    von Bernuth H; Picard C; Puel A; Casanova JL
    Eur J Immunol; 2012 Dec; 42(12):3126-35. PubMed ID: 23255009
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential regulation of interleukin 1 receptor and Toll-like receptor signaling by MEKK3.
    Huang Q; Yang J; Lin Y; Walker C; Cheng J; Liu ZG; Su B
    Nat Immunol; 2004 Jan; 5(1):98-103. PubMed ID: 14661019
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An oligomeric signaling platform formed by the Toll-like receptor signal transducers MyD88 and IRAK-4.
    Motshwene PG; Moncrieffe MC; Grossmann JG; Kao C; Ayaluru M; Sandercock AM; Robinson CV; Latz E; Gay NJ
    J Biol Chem; 2009 Sep; 284(37):25404-11. PubMed ID: 19592493
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IRAK (Pelle) family member IRAK-2 and MyD88 as proximal mediators of IL-1 signaling.
    Muzio M; Ni J; Feng P; Dixit VM
    Science; 1997 Nov; 278(5343):1612-5. PubMed ID: 9374458
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The involvement of the interleukin-1 receptor-associated kinases (IRAKs) in cellular signaling networks controlling inflammation.
    Ringwood L; Li L
    Cytokine; 2008 Apr; 42(1):1-7. PubMed ID: 18249132
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interleukin receptor-associated kinase-4 deficiency impairs Toll-like receptor-dependent innate antiviral immune responses.
    McDonald DR; Brown D; Bonilla FA; Geha RS
    J Allergy Clin Immunol; 2006 Dec; 118(6):1357-62. PubMed ID: 17157666
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The contribution of the Toll-like/IL-1 receptor superfamily to innate and adaptive immunity to fungal pathogens in vivo.
    Bellocchio S; Montagnoli C; Bozza S; Gaziano R; Rossi G; Mambula SS; Vecchi A; Mantovani A; Levitz SM; Romani L
    J Immunol; 2004 Mar; 172(5):3059-69. PubMed ID: 14978111
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Poly(I-C)-induced Toll-like receptor 3 (TLR3)-mediated activation of NFkappa B and MAP kinase is through an interleukin-1 receptor-associated kinase (IRAK)-independent pathway employing the signaling components TLR3-TRAF6-TAK1-TAB2-PKR .
    Jiang Z; Zamanian-Daryoush M; Nie H; Silva AM; Williams BR; Li X
    J Biol Chem; 2003 May; 278(19):16713-9. PubMed ID: 12609980
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dysregulation of LPS-induced Toll-like receptor 4-MyD88 complex formation and IL-1 receptor-associated kinase 1 activation in endotoxin-tolerant cells.
    Medvedev AE; Lentschat A; Wahl LM; Golenbock DT; Vogel SN
    J Immunol; 2002 Nov; 169(9):5209-16. PubMed ID: 12391239
    [TBL] [Abstract][Full Text] [Related]  

  • 35. What the Myddosome structure tells us about the initiation of innate immunity.
    Gay NJ; Gangloff M; O'Neill LA
    Trends Immunol; 2011 Mar; 32(3):104-9. PubMed ID: 21269878
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A central role for the Hsp90.Cdc37 molecular chaperone module in interleukin-1 receptor-associated-kinase-dependent signaling by toll-like receptors.
    De Nardo D; Masendycz P; Ho S; Cross M; Fleetwood AJ; Reynolds EC; Hamilton JA; Scholz GM
    J Biol Chem; 2005 Mar; 280(11):9813-22. PubMed ID: 15647277
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IL-1 receptor-associated kinase 4 is essential for IL-18-mediated NK and Th1 cell responses.
    Suzuki N; Chen NJ; Millar DG; Suzuki S; Horacek T; Hara H; Bouchard D; Nakanishi K; Penninger JM; Ohashi PS; Yeh WC
    J Immunol; 2003 Apr; 170(8):4031-5. PubMed ID: 12682231
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Toll-like receptor 2 dominance over Toll-like receptor 4 in stressful conditions for its detrimental role in the heart.
    Bagchi AK; Akolkar G; Mandal S; Ayyappan P; Yang X; Singal PK
    Am J Physiol Heart Circ Physiol; 2017 Jun; 312(6):H1238-H1247. PubMed ID: 28432060
    [TBL] [Abstract][Full Text] [Related]  

  • 39. IL-1 receptor-associated kinase 1 mediates protection against Staphylococcus aureus infection.
    Verdrengh M; Thomas JA; Hultgren OH
    Microbes Infect; 2004 Nov; 6(14):1268-72. PubMed ID: 15555532
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mutational analysis identifies residues crucial for homodimerization of myeloid differentiation factor 88 (MyD88) and for its function in immune cells.
    Loiarro M; Volpe E; Ruggiero V; Gallo G; Furlan R; Maiorino C; Battistini L; Sette C
    J Biol Chem; 2013 Oct; 288(42):30210-30222. PubMed ID: 24019529
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.